PMAM
CLLS

Picton Mahoney Asset Management’s Cellectis CLLS Stock Holding History

Picton Mahoney Asset Management’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,200
Closed -$245K – 196
2017
Q1 		$245K Sell
10,200
-4,400
-30% -$92.4K 0.02% 175
2016
Q4 		$247K Buy
14,600
+6,100
+72% +$113K 0.02% 165
2016
Q3 		$205K Sell
8,500
-15,400
-64% -$403K 0.01% 210
2016
Q2 		$635K Sell
23,900
-2,900
-11% -$85K 0.04% 190
2016
Q1 		$737K Buy
26,800
+7,750
+41% +$187K 0.05% 187
2015
Q4 		$591K Sell
19,050
-183,250
-91% -$5.56M 0.04% 193
2015
Q3 		$5.33M Buy
202,300
+63,700
+46% +$2.13M 0.31% 96
2015
Q2 		$5M Buy
138,600
+133,600
+2,672% +$4.69M 0.25% 104
2015
Q1 		$173K Buy
+5,000
New +$181K 0.01% 198

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Picton Mahoney Asset Management's CLLS Position: Q2 2017 in Review

Picton Mahoney Asset Management sold out of Cellectis (CLLS) in Q2 2017, closing a stake of 10,200 shares — an estimated $245K sold.

Picton Mahoney Asset Management first reported a position in CLLS in Q1 2015 and held it in 9 quarters. The position peaked at $5.33M in Q3 2015. 41 funds tracked by Wall St. Rank hold CLLS as of Q2 2017.

  • Picton Mahoney Asset Management reported no remaining Cellectis position as of Q2 2017 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 10,200 Cellectis shares in Q2 2017, an estimated $245K.
  • Picton Mahoney Asset Management first reported a position in Cellectis in Q1 2015 and held it in 9 quarters.
  • Picton Mahoney Asset Management's Cellectis position peaked at $5.33M in Q3 2015.
  • 41 funds tracked by Wall St. Rank held Cellectis as of Q2 2017.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.